Sankala Group’s CME Group CME Stock Holding History

Sankala Group’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$363K	Buy	1,332 +783	+143%	+$217K	0.24%	100
2026 Q1	$164K	Buy	549 +126	+30%	+$37.4K	0.13%	136
2025 Q4	$135K	Buy	+423	New	+$115K	0.11%	152

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Sankala Group's CME Position: Q2 2026 in Review

Sankala Group increased its CME Group (CME) stake by 143% in Q2 2026, buying an estimated $217K and bringing the position to 1,332 shares worth $363K. The position accounts for 0.24% of the portfolio, ranked #100.

Sankala Group first reported a position in CME in Q4 2025 and has held it in 3 quarters since. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Sankala Group held 1,332 shares of CME Group worth $363K as of Q2 2026.
Sankala Group bought 783 CME Group shares in Q2 2026, an estimated $217K.
CME Group made up 0.24% of Sankala Group's portfolio in Q2 2026, its #100 holding.
Sankala Group first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.